In their study, Hutchins et al. reported the sensitivities and specificities of four studies using the same clinical variables that were used in our research (fever, rashes, and at least one of cough, coryza, and conjunctivitis; serological confirmation by IgM or enzyme immunoassays (EIA)). This evidence concerns the gene CD40LG and conjunctivitis.